The Gastroesophageal Reflux Disease Therapeutics Global Market Report 2023, provides comprehensive information on the gastroesophageal reflux disease therapeutics market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Gastroesophageal Reflux Disease Therapeutics Market’s Growth:
The global gastroesophageal reflux disease therapeutics market size is expected to grow from $5.56 billion in 2022 to $5.78 billion in 2023 at a compound annual growth rate (CAGR) of 3.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of gastroesophageal reflux disease therapeutics market is expected to reach $6.82 billion in 2027 at a CAGR of 4.2%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12058&type=smp
Product innovations are the key trend gaining popularity in the gastroesophageal reflux disease therapeutics market. Major companies operating in the gastroesophageal reflux disease therapeutics market are focusing on innovative medications to sustain their position in the market. For instance, in March 2021, Xiromed LLC, a US-based integrated generic company, launched Omeprazole Delayed-Release Capsules (generic to Prilosec) to treat frequent heartburn in gastroesophageal reflux. Omeprazole is a proton pump inhibitor (PPI) medication designed to treat some stomach and esophageal issues (such as acid reflux and ulcers) by lowering the quantity of acid produced by the stomach that alleviating symptoms such as heartburn, trouble swallowing, and persistent cough. This drug helps cure acid damage to the stomach and esophagus, prevents ulcers, and may help prevent esophageal cancer.
The gastroesophageal reflux disease therapeutics market is segmented:
1) By Type: Branded, Generic
2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets
4) By Application: Crohn’s Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis
North America was the largest region in the gastroesophageal reflux disease therapeutics market in 2022.
The table of contents in TBRC’s gastroesophageal reflux disease therapeutics market report includes:
.
.
.
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Dextrose refers to a basic sugar derived from corn or wheat that…
Overview and Scope Device as a Service refers to a subscription-based service that provides businesses…
Overview and Scope Dermatology OTC medications are non-prescription drugs used to prevent and cure conditions…
Overview and Scope Dental milling machines refer to computer-controlled small cutting devices utilized in dentistry…
Overview and Scope Demand planning solutions refer to the process of software or systems that…
Overview and Scope Refinish paint, also known as refinishing paint, refers to a type of…